Gastric Cancer Archives - Cancer Therapy Advisor

Gastric Cancer

Managing adverse effects after starting a TKI can be challenging, and health care practitioners ofte

Differences in the Diagnosis, Management, and Outcomes of Hispanic Patients With Gastric Cancer Revealed

A retrospective study of patients with gastric cancer in the United States showed differences in patient- and disease-related characteristics, as well as different frequencies of staging laparoscopy, treatment/surgical approaches, and specific clinical outcomes, for those of Hispanic compared with non-Hispanic ethnicity. This study was published in the Journal of Surgical Oncology. In the US, the incidence of gastric…

FDA_new indication

Lonsurf Gains Metastatic Gastric Cancer Indication

The Food and Drug Administration has approved Lonsurf (trifluridine and tipiracil; Taiho Oncology) for the treatment of adult patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma previously treated with at least 2 prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, HER2/neu-targeted therapy. The approval was based…

Next post in ESMO GI 2018